Stage IIIB(N2) Non-small Cell Lung Cancer
1 clinical trials · Condition
◉ Watch Stage IIIB(N2) Non-small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab and Chemotherapy Neoadjuvant/Adjuvant of NSCLC (NCT05894889) | Peking University | 2024-01-30 |
Track Stage IIIB(N2) Non-small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.